4,5-Dimethyl-1,2-phenylenediamine
Star0
Identification
- Generic Name
- 4,5-Dimethyl-1,2-phenylenediamine
- DrugBank Accession Number
- DB03180
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 136.1943
Monoisotopic: 136.100048394 - Chemical Formula
- C8H12N2
- Synonyms
- 4,5-Dimethyl-o-phenylenediamine
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UNicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase Not Available Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as o-xylenes. These are aromatic compounds that contain a o-xylene moiety, which is a monocyclic benzene carrying exactly two methyl groups at the 1- and 2-positions.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Benzene and substituted derivatives
- Sub Class
- Xylenes
- Direct Parent
- o-Xylenes
- Alternative Parents
- Aniline and substituted anilines / Primary amines / Organopnictogen compounds / Hydrocarbon derivatives
- Substituents
- Amine / Aniline or substituted anilines / Aromatic homomonocyclic compound / Hydrocarbon derivative / O-xylene / Organic nitrogen compound / Organonitrogen compound / Organopnictogen compound / Primary amine
- Molecular Framework
- Aromatic homomonocyclic compounds
- External Descriptors
- a small molecule (CPD-11237)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1OJ9D3R6NH
- CAS number
- 3171-45-7
- InChI Key
- XSZYBMMYQCYIPC-UHFFFAOYSA-N
- InChI
- InChI=1S/C8H12N2/c1-5-3-7(9)8(10)4-6(5)2/h3-4H,9-10H2,1-2H3
- IUPAC Name
- 4,5-dimethylbenzene-1,2-diamine
- SMILES
- CC1=CC(N)=C(N)C=C1C
References
- General References
- Not Available
- External Links
- PubChem Compound
- 76635
- PubChem Substance
- 46505286
- ChemSpider
- 69099
- ZINC
- ZINC000000153351
- PDBe Ligand
- 150
- PDB Entries
- 1l4f
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 13.1 mg/mL ALOGPS logP 0.88 ALOGPS logP 1.34 Chemaxon logS -1 ALOGPS pKa (Strongest Basic) 5.23 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 52.04 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 45.54 m3·mol-1 Chemaxon Polarizability 15.79 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.8734 Blood Brain Barrier + 0.8259 Caco-2 permeable + 0.7484 P-glycoprotein substrate Non-substrate 0.6601 P-glycoprotein inhibitor I Non-inhibitor 0.9519 P-glycoprotein inhibitor II Non-inhibitor 0.995 Renal organic cation transporter Non-inhibitor 0.9153 CYP450 2C9 substrate Non-substrate 0.8725 CYP450 2D6 substrate Non-substrate 0.8557 CYP450 3A4 substrate Non-substrate 0.784 CYP450 1A2 substrate Non-inhibitor 0.6646 CYP450 2C9 inhibitor Non-inhibitor 0.8402 CYP450 2D6 inhibitor Non-inhibitor 0.9679 CYP450 2C19 inhibitor Non-inhibitor 0.8681 CYP450 3A4 inhibitor Non-inhibitor 0.9229 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.6402 Ames test AMES toxic 0.9196 Carcinogenicity Carcinogens 0.5564 Biodegradation Not ready biodegradable 0.98 Rat acute toxicity 2.6347 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9731 hERG inhibition (predictor II) Non-inhibitor 0.9198
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-000i-1900000000-512321926f73d60a5e8f Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0079-1900000000-4daaf8d3dda0466da92e Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-00di-5900000000-18787c2ec7f72da0f04e Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-000i-0900000000-2b7ae405fbbdb08ca17b Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-000i-1900000000-c7e44a9d450f7059c05f Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0fbc-9400000000-a8cd869a90ff41104b55 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-02t9-9400000000-970192cdba34c1cf0c1b Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 130.3726663 predictedDarkChem Lite v0.1.0 [M-H]- 130.3138663 predictedDarkChem Lite v0.1.0 [M-H]- 129.49959 predictedDeepCCS 1.0 (2019) [M+H]+ 131.2770663 predictedDarkChem Lite v0.1.0 [M+H]+ 131.0588663 predictedDarkChem Lite v0.1.0 [M+H]+ 132.82512 predictedDeepCCS 1.0 (2019) [M+Na]+ 130.3788663 predictedDarkChem Lite v0.1.0 [M+Na]+ 130.4559663 predictedDarkChem Lite v0.1.0 [M+Na]+ 141.97667 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
- Kind
- Protein
- Organism
- Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720)
- Pharmacological action
- Unknown
- General Function
- Nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferase activity
- Specific Function
- Catalyzes the synthesis of alpha-ribazole-5'-phosphate from nicotinate mononucleotide (NAMN) and 5,6-dimethylbenzimidazole (DMB).
- Gene Name
- cobT
- Uniprot ID
- Q05603
- Uniprot Name
- Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
- Molecular Weight
- 36612.305 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52